SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. ($UUUU) is trending amid speculation around upcoming earnings and potential government contracts related to uranium and rare earth elements. Community discussions highlight the stock's volatility, with some traders pointing to unusual options activity and anticipating a significant price movement. Others suggest that any pullback represents a buying opportunity, citing the company's strategic importance in securing domestic supply chains.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

NewcelX Ltd.

NCEL is trending as investors grapple with the implications of its recent merger and reverse stock split, with some expressing confusion and concern over trading discrepancies and stock valuations. Community discussions revolve around the potential for a short squeeze and the company's future prospects post-merger. The merger with Kadimastem is seen by some as a positive catalyst, while others remain skeptical about the combined entity's valuation and potential.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors discuss its high valuation and potential ahead of earnings, with some pointing to strong AI growth and government contracts as reasons for optimism. The community is debating whether the stock can maintain its momentum and if it will beat expectations. Discussions include potential stock splits and comparisons to other high-growth tech companies.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals ($BCRX) is trending as investors anticipate upcoming earnings and key updates on its pipeline, including BCX17725 for Netherton syndrome. Community discussions focus on the potential for a positive conference call with improved guidance, overshadowing concerns about debt and valuation. Optimism surrounds the integration of Astria's assets and potential label expansion for Orladeyo, as analysts project earnings growth.

Space and Time is the Microsoft-backed blockchain for ZK-proven data. Powered by Proof of SQL, a sub-second ZK coprocessor, Space and Time allows smart contracts, AI agents, and onchain applications to query onchain and offchain data at scale and verify the results with cryptographic proofs. The foundation of Space and Time is a decentralized layer 1 blockchain where validators verify every piece of data that gets inserted into the network, updating and signing cryptographic commitments on the data before recording them onchain. Developers can query this data via Proof of SQL and receive back a trustless, tamperproof result onchain. Space and Time allows smart contracts to query over the full history of major blockchains and offchain sources in a verifiable way, enabling a new generation of sophisticated, data-driven onchain apps.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time ($SXT) is trending amid community excitement surrounding its technology and partnerships, particularly with Microsoft and Chainlink. Discussions center on its potential for growth in the AI and decentralized data space, with some highlighting recent integrations and others anticipating a breakout. The community is closely watching for further developments that could drive broader adoption and price appreciation.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

GILD is trending due to recent earnings and analyst upgrades, though the stock's reaction is mixed, with some questioning if investor expectations weren't fully met. Community discussions revolve around the company's HIV and oncology pipeline, potential acquisitions (such as RCUS or XLO), and the impact of regulatory decisions. Several actionable alerts and technical analyses are being shared, with call options being a popular strategy.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

UNG is trending amid speculation around winter weather and potential supply constraints, with some traders anticipating a significant rally. Community discussions revolve around technical indicators, potential breakout levels, and the impact of data center energy consumption on natural gas demand. Despite strong storage levels, expectations of increased demand and potential disruptions are fueling bullish sentiment.

Direxion Shares ETF Trust - Direxion Daily Junior Gold Miners Index Bull 2X Shares

Direxion Daily Junior Gold Miners Index Bull 2X Shares

JNUG is trending due to LiquidTheta's LEAPS options alerts, sparking community interest in potential ROI. Additionally, news of China and Canada expanding trade and energy ties could provide tailwinds. However, concerns about consumer recession, layoffs, and banking stress are also circulating, adding complexity to the discussion around JNUG and junior gold miners.

Peloton Interactive, Inc. provides an at-home fitness platform for live and on-demand indoor cycling classes. The firm pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its members. It operates through the Connected Fitness Products and Subscription segments. The Connected Fitness Products segment includes the sales of bikes, tread & related accessories. The Subscription segment refers to the monthly subscription and credits from live studio classes. The company was founded by John Foley, Graham Stanton, Thomas Cortese, Yony Feng, and Hisao Kushi in 2012 and is headquartered in New York, NY.

Peloton Interactive Inc - Ordinary Shares - Class A

Peloton Interactive Inc

Peloton is trending as the community discusses its potential for a turnaround, fueled by recent analyst upgrades and speculation around new AI-integrated products. Community members are debating whether the stock is poised for a Carvana-like surge, while others caution about the impact of the broader economic environment and short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4 Leveraged ETFs With Double-Digit Gains in July

DFEN, USD, UTSL and WILD posted double-digit gains in July as tech strength, trade optimism and Fed stability lifted markets.

Best Leveraged ETFs of the Second Quarter of 2025

URAA, FNGU, USD, LMBO and DFEN soared more than 60% in Q2 as AI-driven tech, a dovish Fed and momentum buying lifted leveraged ETF returns.

Best Leveraged ETFs of the First Half of 2025

GDXU, KORU, DFEN and others soared in the first half of 2025 as AI momentum, global stimulus, and gold gains fueled leveraged ETF outperformance.


Shares of Boeing Co. (BA) fell over 4% on Tuesday, dragging retail sentiment down, after the company revealed a new hurdle in its efforts to certify the 777X, its newest widebody jet.Boeing reportedly grounded its entire 777X test fleet after discovering a damaged thrust link, a key engine mounting structure, on a 777-9 during routine maintenance. This failure signifies a critical design flaw, causing delays in the already-behind-schedule certification process. &nbsp;Following the news, retail investor sentiment on Stocktwits shifted deeper into ‘bearish’ territory (29/100), with a significant increase in message volume. &nbsp;<figure class="image"><a href="https://stocktwits.com/symbol/BA"><img style="aspect-ratio:1310/316;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BA_sentiment_and_message_volume_Aug_20_e0476b4234.png" alt="BA sentiment and message volume Aug 20.png" width="1310" height="316"></a><figcaption>BA sentiment and message volume Aug 20</figcaption></figure>Some users expressed concerns about Boeing's competence and potential regulatory issues stemming from this incident.<stembedurl>https://stocktwits.com/Fredafzal1/message/583533076</stembedurl>This development presents the first major challenge for Boeing's new CEO, Kelly Ortberg, who took charge earlier this month and <a href="https://stocktwits.com/news/markets/equity/boeing-retail-sentiment-bullish-on-new-ceo-ortberg/c7HyVAFRRs">boosted investor sentiment</a>.RBC Capital analyst Ken Herbert reportedly expects the grounding to push 777x delivery expectations “to the right, and potentially into 2026,” adding that the program’s approval period would likely be prolonged.Boeing has faced a series of issues in recent years, including fatal crashes, production problems, and safety incidents.However, August has presented a few positive catalysts, such as increased orders and deliveries for the previous month, a major aircraft order from EL AL Israel Airlines, and reports of potential freighter deals with Saudi Arabia.Despite the recent setbacks, Boeing's stock price is still up over 1% since Ortberg took over, suggesting the broader market retains some confidence in his leadership.However, retail investors are turning cautious, worried about potential regulatory fallout and further delays impacting the 777X program.

This development presents the first major challenge for Boeing's new CEO, Kelly Ortberg, who took charge earlier this month. Photo via Flickr

Boeing Stock Slides On Fresh 777X Woes, Retail Investor Optimism Wanes

A Wall Street analyst predicts the grounding could push 777X delivery expectations into 2026, signaling a prolonged approval period.

Equity

A Wall Street analyst predicts the grounding could push 777X delivery expectations into 2026, signaling a prolonged approval period.


Boeing Co. (BA) is experiencing a much-needed shot of optimism, as its stock price surged over 3% on the very first day of new CEO Kelly Ortberg's tenure. Retail investors too seem to be buying into the planemaker’s new chapter.Stocktwits sentiment for BA has flipped from ‘neutral’ to ‘bullish’ (57/100) in a day, indicating a newfound confidence in Boeing's future, which appears to be driven by a combination of Ortberg's strategic decisions and a yearning for change among investors.<figure class="image"><a href="https://stocktwits.com/symbol/BA"><img style="aspect-ratio:1320/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BA_sentiment_and_message_volume_score_Aug_9_3bd82a722d.png" alt="BA sentiment and message volume score Aug 9.png" width="1320" height="318"></a><figcaption>BA sentiment and message volume score Aug 9 9.30 am ET</figcaption></figure>Ortberg has decided to relocate his office to Seattle, the company's historical heartland. This move, seen as long overdue by many, signifies a return to Boeing's manufacturing roots.The CEO himself emphasized the importance of proximity to production in a letter to employees, stating, "We need to get closer to the production lines and development programs."He wasted no time putting his words into action, reportedly spending his first day on the factory floor in Renton, Washington, the birthplace of the troubled 737 Max planes. &nbsp;Retail investors on Stocktwits, where Boeing has 185,000 followers, showered praise. One user lauded Ortberg’s focus on safe production increases, highlighting it as the key to unlocking a domino effect of positive outcomes for salaries, stock price, and debt reduction.<stembedurl>https://stocktwits.com/Salahadin666/message/582423227</stembedurl><stembedurl>https://stocktwits.com/BlueFir/message/582421775</stembedurl>Others pointed to Ortberg's engineering background as a perfect fit for leading a manufacturing giant, predicting a significant rise in stock price within the next few years.<stembedurl>https://stocktwits.com/JustForTodayReborn/message/582385865</stembedurl>Boeing has undeniably faced its share of struggles in recent years. From quality issues that led to fatal crashes to more terrifying incidents such as a door plug blowing off a fuselage mid-air, the company's reputation has taken a beating.Calhoun, Ortberg's predecessor, inherited a crisis-ridden Boeing in 2020 and saw the stock price nearly halve during his tenure. The COVID-19 pandemic exacerbated the company's woes. &nbsp;However, analysts like Noah Poponak of Goldman Sachs see a glimmer of hope. Earlier this week, he acknowledged the turbulence of Q2 2024 but highlighted increased production rates and Ortberg's appointment as factors that could alleviate past uncertainties. Poponak maintained a ‘Buy’ rating for BA stock, albeit with a slightly lowered price target. &nbsp;The combined factors of Ortberg's strategic moves, retail investor optimism, and analyst support are painting a cautiously optimistic picture for Boeing's future.

Boeing 777 airplane. Photo via GoodFon.com

Boeing’s New CEO Lifts Retail Sentiment Into ‘Bullish’ Zone After Day 1 On Job: What’s He Doing?

Boeing Co. (BA) is experiencing a much-needed shot of optimism, as its stock price surged over 3% on the very first day of new CEO Kelly Ortberg's tenure. Retail investors too seem to be buying into the planemaker’s new chapter.

Boeing’s New CEO Lifts Retail Sentiment Into Bullish

While challenges undoubtedly remain, there's a renewed sense of purpose under Ortberg's leadership. Only time will tell if Boeing can truly return to its former glory, but the initial signs among retail investors are encouraging.

Direxion Shares ETF Trust - Direxion Daily Aerospace & Defense Bull 3X Shares

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$73.94
Prev Close	$73.44
Open	$73.54
Dividend Yield	N/A
50-Day Moving Average	$65.52
Beta	N/A
Avg. Volume	212,048.29
PE Ratio	N/A

52-Week High	$79.38
52-Week Low	$17.64
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

DFEN
Direxion Daily Aerospace & Defense Bull 3X Shares

Feed

News

Sentiment

Fundamentals

Info

Latest DFEN News

DFENDirexion Daily Aerospace & Defense Bull 3X Shares